Gross Margin

Lead Real Estate’s ENT TERRACE hotels secure prestigious Booking.com awards, reflecting a successful strategy in Japan's booming extended-stay market.

A new facility in Estonia is breaking Europe's reliance on China for critical minerals essential for electric vehicles and wind turbines.

As Brookfield Residential preps its Q1 2026 earnings, all eyes are on what its results will signal for the broader North American real estate market.

After a major financial overhaul, solar firm SUNation Energy is exploring a sale, a move that could reshape its future and ripple through the hot M&A market.

ScottsMiracle-Gro divests its cannabis-focused Hawthorne unit to Vireo Growth, a strategic pivot to boost margins and exit a volatile market.

Leetx and Centron debut an integrated digital ecosystem in North America, promising to fix critical scalability and precision issues for manufacturers.

China's EdTech giant TAL is set to report Q4 earnings. Investors are watching closely to see if its pivot to AI and smart devices is a winning strategy.

The retailer posts modest annual growth despite a tough Q4, as international gains and efficiency drives offset major headwinds in its Canadian operations.

Vancouver's SalesCloser Technologies begins trading on the TSXV. Can its autonomous AI agents revolutionize the multi-billion dollar sales industry?

EDERRA's new partnership with Cepham signals a shift in wellness, blending brand transparency with manufacturing science to lead the functional food market.

The race for AI supremacy pushed semiconductor equipment sales to an unprecedented high in 2025, as Asia widens its manufacturing investment lead over the West.

With its Q1 earnings call on May 7, STARZ faces investor scrutiny on subscriber growth, content strategy, and its path to profitability post-spinoff.

Harvard Business Review's 2025 prize signals a new era for leadership, rewarding a practical framework that moves beyond AI hype to strategic implementation.

With new clinical trial data showing its AI is superior for complex AFib, Volta Medical heads to a major conference to change the standard of care.

Facing a storm of overcapacity, geopolitical risks, and a rising China, Europe's polyolefins sector is fighting for its future. Can it survive?

Outset Medical appoints Derick Elliott as commercial EVP, a strategic move to accelerate its Tablo dialysis system and capitalize on the hospital insourcing trend.

With diagnostic sales fueling a diverse therapeutic arsenal, Telix reaffirms blockbuster guidance and advances pivotal trials for prostate, brain, and kidney cancers.

The 6th-gen Toyota RAV4 ditches gas engines, betting its all-hybrid lineup and new tech can keep it on top of the hyper-competitive small SUV market.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.